Literature DB >> 7907148

Pyridobenzoxazepine and pyridobenzothiazepine derivatives as potential central nervous system agents: synthesis and neurochemical study.

J F Liégeois1, F A Rogister, J Bruhwyler, J Damas, T P Nguyen, M O Inarejos, E M Chleide, M G Mercier, J E Delarge.   

Abstract

In order to characterize the pharmacological profile of the different chemical classes of pyridobenzazepine derivatives, a series of N-methylpiperazinopyrido[1,4]- and -[1,5]- benzoxa- and benzothiazepine derivatives were prepared. The affinities for D2, D1, 5-HT2, and cholinergic (M) receptors were measured. In comparison to dibenzazepine reference compounds, a strong decrease of the affinities was observed, less pronounced, however, for the substituted analogues. Oxazepine and thiazepine analogues like clozapine (except 8-chloro-6-(4-methylpiperazin-1-yl)-pyrido[2,3-b][1,4]benzoxazepin e (9) and 8-chloro-6-(4-methylpiperazin-1-yl)pyrido[2,3-b][1,4]- benzothiazepine (11)) were found to be inactive against apomorphine stereotypies. In the open-field test in rats, different molecules showed a high disinhibitory activity as observed with anxiolytic drugs. Moreover, 8-chloro-5-(4-methylpiperazin-1-yl)pyrido[2,3-b][1,5]benzoxazepine (14) presented a clozapine-like profile that was confirmed in the behavioral model in dogs and showed most of the behavioral characteristics described for antipsychotic drugs. Its neurochemical profile, in particular the 5-HT2/D2 ratio, was also compatible with atypical antipsychotic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907148     DOI: 10.1021/jm00030a011

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach.

Authors:  Jinbao Xiang; Zhuoqi Zhang; Yan Mu; Xianxiu Xu; Sigen Guo; Yongjin Liu; Daniel P Russo; Hao Zhu; Bing Yan; Xu Bai
Journal:  ACS Comb Sci       Date:  2016-04-15       Impact factor: 3.784

2.  8-Chloro-5-(4-phenethylpiperazin-1--yl)pyrido[2,3-b][1,5]benzoxazepine.

Authors:  Ben Capuano; Ian T Crosby; Craig M Forsyth; Edward J Lloyd; Amelia Vom; Elizabeth Yuriev
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-09-06

3.  Sequential Ugi reaction/base-induced ring closing/IAAC protocol toward triazolobenzodiazepine-fused diketopiperazines and hydantoins.

Authors:  Robby Vroemans; Fante Bamba; Jonas Winters; Joice Thomas; Jeroen Jacobs; Luc Van Meervelt; Jubi John; Wim Dehaen
Journal:  Beilstein J Org Chem       Date:  2018-03-14       Impact factor: 2.883

4.  [1,5]-Hydride Shift-Cyclization versus C(sp2)-H Functionalization in the Knoevenagel-Cyclization Domino Reactions of 1,4- and 1,5-Benzoxazepines.

Authors:  Dóra Szalóki Vargáné; László Tóth; Balázs Buglyó; Attila Kiss-Szikszai; Attila Mándi; Péter Mátyus; Sándor Antus; Yinghan Chen; Dehai Li; Lingxue Tao; Haiyan Zhang; Tibor Kurtán
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

5.  A One-Pot Synthesis of Oxazepine-Quinazolinone bis-Heterocyclic Scaffolds via Isocyanide-Based Three-Component Reactions.

Authors:  Shabnam Shaabani; Ahmad Shaabani; Monika Kucerakova; Michal Dusek
Journal:  Front Chem       Date:  2019-09-18       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.